Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has ...

Since April 18, 2023, the United States Patent and Trademark Office (USPTO) has been issuing and publishing patent grants ...

There are many valuable benefits of registering one’s trademark with the United States Patent and Trademark Office (USPTO). A cursory Internet ...

Nexalin’s method aims to treat substance use disorders by stimulating neural pathways linked to addiction and withdrawal ...

GM has filed a patent application for a power-operated seat armrest system, potentially offering enhanced comfort for ...

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to ...

This milestone further strengthens Nexalin’s intellectual property portfolio and affirms the potential of its proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology, a non-invasive and ...

Anixa Biosciences (ANIX) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent related ...

NEW YORK, NY / ACCESS Newswire / April 14, 2025 /Classover Holdings, Inc. (the "Company") (Nasdaq:KIDZ, KIDZW), a leader in ...

today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new patent related to the Company's innovative breast cancer vaccine technology.

The United States Court of Appeals for the Federal Circuit dismissed a legal claim against the NFL’s New Orleans Saints from ...